Invokana
Invokana

4.82
For patients managing diabetes, this generic medicine inhibits renal glucose reabsorption to lower blood sugar levels.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Canagliflozin
Reference Brand
Canagliflozin
Product Origin
Generic Alternative
Reference Manufacturer
Janssen
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidiabetics
Product Category
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
Pharmacological Class
SGLT2 Inhibitor
Clinical Indications
Manufacturer Description
Indicated to address elevated blood glucose to manage diabetes symptoms and alleviate glycemic strain.
Mechanism of Action
Inhibits SGLT2 in proximal renal tubules, lowering glucose reabsorption so that excess glucose is cleared through urine.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Severe renal impairment, Diabetic ketoacidosis
Severe Adverse Events
Fournier's gangrene — requires immediate medical attention, Lower limb amputation risk — requires immediate medical attention, Diabetic ketoacidosis — requires immediate medical attention
Common Side Effects
Increased urination, Stuffy nose, Nausea
Uncommon Side Effects
Urinary tract infection, Genital yeast infection, Hyperkalemia
Drug Interactions
Insulin, Diuretics, Rifampin
Pregnancy Safety Warnings
TGA Category C: Avoid during second and third trimesters. Breastfeeding: Not recommended.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Invokana is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to order Contraception Australia - Levlen ED Australia